Titolo | Pubblicato in | Anno |
---|---|---|
Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome | ARTHRITIS & RHEUMATOLOGY | 2015 |
S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH | Pediatric Rheumatology online journalPEDIATRIC RHEUMATOLOGY ONLINE JOURNAL | 2015 |
INHIBITION OF NATURAL KILLER (NK) CELL CYTOTOXICITY BY INTERLEUKIN-6: IMPLICATIONS FOR THE PATHOGENESIS OF MACROPHAGE ACTIVATION SYNDROME (MAS) | PEDIATRIC BLOOD & CANCER | 2015 |
Erratum to Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis [EMBO Mol Med (2015) 7: 102-123]. DOI 10.15252/emmm.201404127 | EMBO MOLECULAR MEDICINE | 2015 |
I have a background in innate immunity and in cellular/molecular biology. I am interested in molecular mechanisms controlling the induction/reversal of Epithelial to Mesenchymal Transition (EMT) and fibrosis. In particular, I focused my investigation in the role of both extracellular mediators and biomechanical/biophisical cues in the induction of cellular plasticity and signalling pathways implicated. I recently studied the interplay between Caveolin1, a plasma membrane mechanotransducer, and YAP/TAZ, effectors of a main biomechanical pathway, in the induction of peritoneal fibrosis.
I am presently involved in research projects related to biomechanical regulation of EMT and to the control of EMT induction/reversal by epigenetic factors. Moreover, I am interested in the role of infections in the modulation of epithelial cell plasticity.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma